Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective

BACKGROUND AND PURPOSE: Plaque psoriasis is a chronic inflammatory disease with skin manifestations that affect the patients’ quality of life negatively. The prevalence of psoriasis is approximately 2-3% worldwide and appears to be still on the increase. Due to the stigma problems, psoriasis has a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zargaran, Marzieh, Soleymani, Fatemeh, Nasrollahi, Saman Ahmad, Seyedifar, Meysam, Rahaghi, Mohammad Mehdi Ashrafian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356716/
https://www.ncbi.nlm.nih.gov/pubmed/34447446
http://dx.doi.org/10.4103/1735-5362.319576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356716/
https://www.ncbi.nlm.nih.gov/pubmed/34447446
http://dx.doi.org/10.4103/1735-5362.319576

Ejemplares similares